Cargando…
Calcium Channels as Novel Therapeutic Targets for Ovarian Cancer Stem Cells
Drug resistance in epithelial ovarian cancer (EOC) is reportedly attributed to the existence of cancer stem cells (CSC), because in most cancers, CSCs still remain after chemotherapy. To overcome this limitation, novel therapeutic strategies are required to prevent cancer recurrence and chemotherapy...
Autores principales: | Lee, Heejin, Kim, Jun Woo, Kim, Dae Kyung, Choi, Dong Kyu, Lee, Seul, Yu, Ji Hoon, Kwon, Oh-Bin, Lee, Jungsul, Lee, Dong-Seok, Kim, Jae Ho, Min, Sang-Hyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177693/ https://www.ncbi.nlm.nih.gov/pubmed/32230901 http://dx.doi.org/10.3390/ijms21072327 |
Ejemplares similares
-
Repositioning Trimebutine Maleate as a Cancer Treatment Targeting Ovarian Cancer Stem Cells
por: Lee, Heejin, et al.
Publicado: (2021) -
Combined Poziotinib with Manidipine Treatment Suppresses Ovarian Cancer Stem-Cell Proliferation and Stemness
por: Lee, Heejin, et al.
Publicado: (2020) -
The histone lysine methyltransferase SETD8 regulates angiogenesis through HES-1 in human umbilical vein endothelial cells
por: Choi, Dong Kyu, et al.
Publicado: (2020) -
Antiplatelet Effect of Clopidogrel Can Be Reduced by Calcium-Channel Blockers
por: Seo, Kwon-Duk, et al.
Publicado: (2014) -
D-Mannitol Induces a Brown Fat-like Phenotype via a β3-Adrenergic Receptor-Dependent Mechanism
por: Jeon, Hui-Jeon, et al.
Publicado: (2021)